Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.79%) to 10458.50, DAX (1.35%) to 25104.36, CAC40 (1.22%) to 7769.21, STOXX 600 (1.00%) to 630.25

Oct 07 ,2026

  • Synopsis:

    • European indices have ended in negative territory, except for Denmark and Swizterland. French asset selloff the big ongoing development today with country's stocks and bonds under pressure. Far-right 2027 presidential candidate Le Pen's pledged government spending cuts prompted relief in OATs after yields hit multi-decade highs yesterday. However, Le Pen's proposal viewed as challenging to deliver among analysts and the press. At same time, Finance Minister Lescure said government ready to bypass Parliament if budget talks stall, with red lines at a 5% of GDP deficit cap and no growth-damaging measures. Bank of France chief played down need for ECB intervention, but said situation for French bonds is serious. Middle East headlines remain mixed with focus on improving flows, surging costs and pickup in kinetic activity (Iran, Houthis). Houthi attacks damaged Saudi airports. Also some notable pickup in Ukraine and Russian tensions with both striking each other's energy facilities

    • On the macro-front, German industrial production beat expectations, up 2% m/m. UK house prices stalled in September versus a 0.1% gain expected. Also in UK, Chancellor Healey eyes £1B bill rebate as January energy cap threatens to erase VAT cut. In trade developments, EU weighing China hybrid-car import cap

    • In corporate news, energy stocks in focus, with Repsol (REP.SM) reporting Q3 upstream production numbers, while Shell (SHEL.LN) and Equinor (EQNR.NO) releasing Q3 updates ahead of results. Amongst automakers, Porsche (P911.GR) presented its strategy 'Sportwagenschmiede '35' focusing on medium-term ambitions at CMD today, aiming for group sales of €41-45B in the medium term. Elsewhere, Pennon Group (PNN.LN) announced a strategic update with a detailed operational reset from its new CEO, a ~£550M fully underwritten rights issue, and a rebased dividend. In M&A, NLFI announced a fifth trading plan to further reduce its stake in ABN AMRO (ABN.NA)

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers: Health Care +1.80%, Telecom +1.52%, Persnl & HHold Goods +0.63%, Food & Beverage +0.44%, Chemicals +0.03%, Media +0.01%, Retail (0.20%), Autos & Parts (0.33%), Oil & Gas (0.44%), Insurance (0.75%), Real Estate (0.82%), Travel & Leisure (0.95%), Utilities (0.96%)

      • Underperformers: Banks (3.31%), Construct & Mtls (2.19%), Ind Goods & Svcs (2.03%), Basic Resources (1.97%), Technology (1.89%), Financial Svcs (1.63%)

    • Macro:

      • EU seeks to cut trade deficit with China in talks with Beijing (Reuters)

      • France's Battered Bonds Are Starting to Tempt Bargain Hunters (BBG)

      • France and Germany say diesel promise to Trump won't require new stock release (Politico)

      • Musk welcomes German backing for Tesla driver assistance tech as group chases EU approval (Reuters)

      • Bill for new Italian election law passes confidence tests before final vote (Ansa)

      • What we know about the suspected plague case in Russia (FT)

    • Company news:

      • Notable Gainers

        • +14.8% AVON.LN (Avon Technologies £21.65, +2.82) -- FY trading update

        • +13.0% ENRO.SS (Eniro Group SEK34.30, +3.95) -- SEK 2.50/sh extraordinary divi and new distribution policy

        • +10.2% NNIT.DC (NNIT DKK37.30, +3.45) -- weighs divestment of sub SCALES A/S

        • +5.7% NKR.NO (Nekkar NOK14.85, +0.80) -- initiated buy at Pareto

        • +5.6% NCC.B.SS (NCC SEK186.20, +9.70) -- divests Industry business area at an EV of SEK8.2B

        • +5.3% ALK.B.DC (ALK-Abello DKK219.00, +11.00) -- Nordea upgrade

        • +3.9% BOWL.LN (Hollywood Bowl Group £2.59, +0.10) -- FY trading update

        • +3.9% VITR.SS (Vitrolife SEK94.95, +3.60)

        • +2.2% CLAS.B.SS (Clas Ohlson SEK436.40, +9.60) -- Sep sales

        • +2.2% FRVIA.FP (Forvia €9.91, +0.21) -- JV agreement with Anand Group; BofA upgrade

        • +0.3% P911.GR (Porsche €42.37, +0.14) -- presents its strategy 'Sportwagenschmiede '35' focusing on medium-term ambitions at CMD today; aims for group sales of €41-45B in medium term

      • Notable Decliners

        • -20.1% PNN.LN (Pennon Group £3.67, -0.91) -- strategic update; £550M fully underwritten rights issue

        • -9.2% HSW.LN (Hostelworld Group £0.93, -0.09) -- Q3 tradin statement

        • -8.7% ALVIO.FP (Valerio Therapeutics €0.51, -0.05) -- H1 earnings

        • -8.5% BESI.NA (BE Semiconductor Industries €175.80, -16.30) -- UBS downgrade

        • -7.2% WAWI.NO (Wallenius Wilhelmsen NOK165.20, -12.80) -- private placement of 17.2M-shares at NOK 168/sh

        • -6.8% FME.GR (Fresenius Medical Care €40.51, -2.75) -- CEO Helen Giza to step down

        • -6.1% INCH.LN (Inchcape £6.50, -0.42) -- UBS downgrade

        • -5.8% IFX.GR (Infineon Technologies €60.84, -3.73)

        • -4.5% STAN.LN (Standard Chartered £21.63, -1.02) -- partecipates in OKX Hong Kong FinTech fundraise

        • -4.4% ABN.NA (ABN AMRO Bank €40.91, -1.86) -- NLFI announces fifth trading plan to further reduce stake

        • -4.4% HSBA.LN (HSBC Holdings £14.14, -0.64) -- FT articles

        • -2.7% DWNI.GR (Deutsche Wohnen €15.40, -0.42) -- Kepler Cheuvreux downgrade

        • -2.7% FUM.LN (Futura Medical £0.00, -0.00) -- Eroxon "Intense" Home User Test results

        • -2.1% MBG.GR (Mercedes-Benz Group €39.83, -0.87) -- Q3 sales

        • -1.6% EQNR.NO (Equinor NOK403.50, -6.50) -- releases update ahead of Q3 results: Q3 MMB result expected to be above guidance of $400M

        • -1.5% FIA1S.FH (Finnair €4.37, -0.07) -- Sep traffic

        • -0.5% AVOL.SW (Avolta CHF42.90, -0.20) -- Avolta's Hudson secures new 20-year duty-free contract at Seattle-Tacoma International

        • -0.4% REP.SM (Repsol €28.69, -0.12) -- trading statement

        • -0.1% SHEL.LN (Shell Plc £36.47, -0.03) -- Q3 update note

    • EU companies reporting tomorrow:

      • Earnings:

        • DACHs: Suedzucker (SZU.GR), Agrana Beteiligungs (AGR.AV)

        • France: Wallix Group (ALLIX.FP)

        • Nordics: Admicom (ADMCM.FH)

        • UK: Tesco (TSCO.LN), Volution Group (FAN.LN), Next 15 Group (NFG.LN)

      • Trading Update:

        • Benelux: Fagron (FAGR.BB)

        • France: GenSight Biologics (SIGHT.FP)

        • Nordics: TGS-NOPEC Geophysical Co. (TGS.NO), Kid (KID.NO)

        • UK: UNITE Group (UTG.LN)

      • CMD/Events: Schouw & Co (SCHO.DC), Verbio (VBK.GR), doValue (DOV.IM), Faron Pharmaceuticals (FARN.LN) R&D Day, Vodafone Group (VOD.LN) business update call, IG Group Holdings (IGG.LN) business update call

    • Macro-economic updates expected tomorrow:

      • Germany Aug trade balance, Finland Aug industrial production, UK Sep house price balance - RICS, Ireland Sep CPI

  • Data:

    • Economics:

      • Germany Aug Industrial Production +2.0% m/m vs consensus +0.5% and prior (1.1%)

      • UK Sep Lloyds (formerly Halifax) House Price Index 0.0% y/y vs consensus (0.2%) and prior (0.4%)

      • France Aug Trade Balance (€6.1B) vs consensus (€6.5B) and prior revised (€6.6B) from (€6.7B)

      • Norway Aug Manufacturing Production (0.4%) m/m vs consensus +0.1% and prior +0.7%

      • Sweden Sep Preliminary CPI +1.1% y/y vs consensus +1.3% and prior +0.3%

    • Markets:

      • WTI Crude (Nov 26): +$0.05 or +0.06% to $89.49

      • €-$ (0.0072) or (0.64%) to 1.1188

      • £-$ (0.0066) or (0.50%) to 1.3209

      • €-£ (0.0012) to 0.8470

      • S&P 500 (0.41%)

      • Performance year-to-date

        • FTSE 100: +5.31%

        • DAX: +2.51%

        • CAC: (4.67%)

        • MIB: +11.19%

        • Stoxx 600: +6.43%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.